Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Lamm Donald L
Current Opinion in Urology: October 1991
Article: PDF Only

The variable course of carcinoma in situ (CIS) and the high rate and long duration of complete response to baccilus Calmette-Guerin (BCG) immunotherapy now provide patients with the option of postponing radical cystectomy. Immunotherapy with intravesical interferon-α-2b is promising, and there are long-term responses to intravesical chemotherapy, thereby providing further options to the former standard treatment, radical cysto-urethrectomy.

© Lippincott-Raven Publishers.